Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Comment From Breakthrough Breast Cancer On Possible New Genetic Testing Technique
http://www.medicalnewstoday.com/articles/121894.php
Dr Sarah Rawlings, Head of Policy & Involvement at Breakthrough Breast Cancer, says: "Only around 5% of all breast cancer cases are due to inherited faults in known breast cancer genes such as BRCA1 and BRCA2.
New Approach To Detect Rare Genetic Variants Aims To Help Women Evaluate Hormone Replacement Therapy And Breast Cancer Risk
http://www.medicalnewstoday.com/articles/121879.php
Perlegen, a leader in discovering clinically important genetic variations that affect patients' drug response and predisposition to disease, announced today that it has launched a new, proprietary approach to discovering rare genetic variations.
New Tool For Early Diagnosis Of Breast Cancer
http://www.medicalnewstoday.com/articles/121868.php
Scientists from Finland, Germany and the ESRF have developed a new X-ray technique for the early detection of breast cancer. This allows a 3D visualization of the breast with a high spatial resolution and is extremely sensitive to alterations in the tissue, such as those generated by cancer.
ZenBio, Inc. Awarded Grant To Provide Human Breast Cancer Cell System
http://www.medicalnewstoday.com/articles/121865.php
ZenBio, Inc., a privately held biotechnology company, announced that it has been awarded a Phase I SBIR grant to provide a unique human primary cell system for breast cancer research. The $200,000 award from the National Institutes of Health will fund the isolation and culturing of primary human basal and luminal mammary ductal cells for the development of a donor-matched cell system.
Stem Cells May Solve Mystery Of Early Pregnancy Breast Cancer Protection
http://www.medicalnewstoday.com/articles/121807.php
The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal <i>Stem Cell.
----------------------------------------------
** CANCER / ONCOLOGY News **
RAD001 Combined With Sandostatin(R) LAR(R) And As Monotherapy Controls Growth Of Rare Pancreatic Neuroendocrine Tumours
http://www.medicalnewstoday.com/articles/121888.php
New data show that combination treatment with RAD001 (everolimus) and Sandostatin® LAR® (octreotide IM) and RAD001 given alone control tumour growth in patients with pancreatic neuroendocrine tumours (NET), a rare and difficult-to-treat form of cancer.
Compugen Discovers Peptide Drug Candidate For Treatment Of Solid Tumor Cancers And Announces Positive In Vivo Results
http://www.medicalnewstoday.com/articles/121886.php
Compugen Ltd. (NASDAQ:CGEN) announced that its proprietary DAC Blockers Discovery Platform has led to the discovery of CGEN-25008, a novel peptide antagonist of the Clusterin protein. Compugen also announced that recently analyzed in vitro and initial in vivo results from cell-based assays and a lung cancer mouse model indicate that CGEN-25008 reduces the growth rate of several cancer cell lines and significantly enhances the anti-cancer activity of Taxol™, a frequently used cancer chemotherapeutic drug.
Latest RAD001 Study Results Show Further Increase In Time Without Tumor Growth In Patients With Advanced Kidney Cancer
http://www.medicalnewstoday.com/articles/121885.php
New data continue to demonstrate the potential benefit of RAD001 (everolimus) for patients with advanced kidney cancer who have failed standard therapies. Updated study findings from the RECORD-1 (REnal Cell cancer treatment with Oral RAD001 given Daily) study show that patients receiving RAD001 had no tumor growth for nearly 5 months vs.
Tyverb® Demonstrates Encouraging Results In Phase II Study In Advanced Head And Neck Cancer
http://www.medicalnewstoday.com/articles/121883.php
GlaxoSmithKline's (GSK) oral targeted agent Tyverb® (lapatinib) demonstrated single agent activity and improvement in clinical response to the subsequent standard chemoradiation compared to placebo in a Phase II study of advanced squamous cell carcinoma of the head and neck (SCCHN).
Teva Receives EU Marketing Authorization For TevaGrastim(R)
http://www.medicalnewstoday.com/articles/121875.php
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced that the European Commission's Directorate General for Enterprise and Industry granted Teva a Marketing Authorization for its human granulocyte colony stimulating factor (G-CSF) product.
ADAO Applauds Introduction Of Landmark Bill To Ban Asbestos In America And Protect Public Health
http://www.medicalnewstoday.com/articles/121867.php
The Asbestos Disease Awareness Organization (ADAO), the largest organization in the United States dedicated to serving as the voice of asbestos victims, today applauded the U.S. House of Representatives and the Subcommittee on Environment and Hazardous Materials for introducing H.
ZenBio, Inc. Awarded Grant To Provide Human Breast Cancer Cell System
http://www.medicalnewstoday.com/articles/121865.php
ZenBio, Inc., a privately held biotechnology company, announced that it has been awarded a Phase I SBIR grant to provide a unique human primary cell system for breast cancer research. The $200,000 award from the National Institutes of Health will fund the isolation and culturing of primary human basal and luminal mammary ductal cells for the development of a donor-matched cell system.
Clinical Experts Detail How They Use Varian's RapidArc™ Technology To Improve The Precision And Speed Of Cancer Treatments
http://www.medicalnewstoday.com/articles/121849.php
Cancer treatment experts reported today about how they are using RapidArc™ technology from Varian Medical Systems to target tumors more precisely and to speed the delivery of image-guided intensity-modulated arc therapy treatments.
Treatment With New Drug Might Make Tumor Cells More Sensitive To Therapy
http://www.medicalnewstoday.com/articles/121836.php
Scientists at St. Jude Children's Research Hospital have shown that it might be possible to make tumor cells more sensitive to irradiation and some types of chemotherapy by treating them with a drug that cripples their ability to repair DNA damage caused by these therapies.
With Help Of New Compound Viral 'Magic Bullet' Targets Cancer Cells
http://www.medicalnewstoday.com/articles/121814.php
Researchers at McGill University and the affiliated Lady Davis Research Institute of the Jewish General Hospital - along with colleagues at the University of Ottawa and the Ottawa Health Research Institute (OHRI) - report a significant breakthrough in the use of viruses to target and destroy cancer cells, a field known as oncolytic virotherapy.
Three Phase II Ipilimumab Studies Showed Almost Half Of Previously Treated Metastatic Melanoma Patients Alive Beyond One Year
http://www.medicalnewstoday.com/articles/121813.php
Bristol-Myers Squibb announced updated survival data from three Phase II studies of ipilimumab in patients with advanced metastatic melanoma (Stage III or IV), which showed that approximately half of previously-treated patients who received ipilimumab (10 mg/kg) remained alive beyond one year.
Global Lung Cancer Coalition Presents The 3rd Annual Lung Cancer Journalism Awards Competition
http://www.medicalnewstoday.com/articles/121788.php
The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer-related deaths worldwide.<b>Winners receive:</b> -- Global showcase recognising their prize-winning work -- GBP2,000 research grant <b> Enter to win in 3 different categories:</b> -- Best Medical Article -- Best Consumer Article-- Best Broadcast Report<b>Requirements:</b> The entry must have been published or broadcast between 1 September 2007 and 1 September 2008.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Virtual Colonoscopy Finds 90 Per Cent Of Large Growths
http://www.medicalnewstoday.com/articles/121901.php
A new study found that virtual colonoscopy using non invasive X-ray based computed tomography (CT scanning) was 90 per cent effective at finding large pre-cancerous and cancerous growths, but not very effective at finding much smaller growths.
----------------------------------------------
** LUNG CANCER News **
ADAO Applauds Introduction Of Landmark Bill To Ban Asbestos In America And Protect Public Health
http://www.medicalnewstoday.com/articles/121867.php
The Asbestos Disease Awareness Organization (ADAO), the largest organization in the United States dedicated to serving as the voice of asbestos victims, today applauded the U.S. House of Representatives and the Subcommittee on Environment and Hazardous Materials for introducing H.
Pazopanib Shrinks Lung Cancers Before Surgery
http://www.medicalnewstoday.com/articles/121831.php
Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, US researchers report.In a phase II trial, 30 out of 35 patients treated with preoperative pazopanib for a minimum of two weeks saw their tumor size shrink by up to 85%.
Global Lung Cancer Coalition Presents The 3rd Annual Lung Cancer Journalism Awards Competition
http://www.medicalnewstoday.com/articles/121788.php
The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer-related deaths worldwide.<b>Winners receive:</b> -- Global showcase recognising their prize-winning work -- GBP2,000 research grant <b> Enter to win in 3 different categories:</b> -- Best Medical Article -- Best Consumer Article-- Best Broadcast Report<b>Requirements:</b> The entry must have been published or broadcast between 1 September 2007 and 1 September 2008.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Indiana University Melvin And Bren Simon Cancer Center Advances Prostate Cancer Research With PROGRESS
http://www.medicalnewstoday.com/articles/121935.php
Although men may not like to talk about it, prostate cancer is the second most common cause of cancer death among men. September - National Prostate Cancer Awareness Month - is a good time to remind men to talk with their physicians about their risks and screening options.
Nymox's NX-1207 Treatment For Benign Prostatic Hyperplasia (BPH) Enters Phase 3 Development
http://www.medicalnewstoday.com/articles/121874.php
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce that a presentation of clinical trial data from the most recently completed clinical studies of NX-1207, the Company's drug in development for benign prostatic hyperplasia (BPH) will be made by Dr.
GTx Presents Bone Turnover Marker Data And Additional PSA Progression Safety Analysis For Toremifene 80 Mg Phase III ADT Clinical Trial
http://www.medicalnewstoday.com/articles/121871.php
GTx, Inc. (Nasdaq: GTXI) presented a safety analysis demonstrating that fewer men treated with toremifene 80 mg had PSA progression over time compared to placebo in the Phase III clinical trial evaluating toremifene 80 mg for the treatment of multiple serious side effects of androgen deprivation therapy (ADT) for advanced prostate cancer.
Testosterone Activates Similar Genes In Prostate Development And Prostate Cancer
http://www.medicalnewstoday.com/articles/121789.php
Gene activity in prostate cancer is reminiscent of that in the developing fetal prostate, providing further evidence that all cancers are not equal, Johns Hopkins researchers report. The finding could help scientists investigate how to manipulate the genetic program to fight a disease whose biology remains poorly understood despite more than half a century of investigation.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment